MANNKIND CORP's ticker is MNKDXXXX and the CUSIP is 56400P201. A total of 4 filers reported holding MANNKIND CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $463,000 | +16.3% | 724,670 | +12.9% | 0.00% | – |
| Q3 2016 | $398,000 | -54.0% | 641,615 | -14.1% | 0.00% | -100.0% |
| Q2 2016 | $866,000 | -43.0% | 747,030 | -50.8% | 0.00% | -50.0% |
| Q1 2016 | $1,518,000 | -89.4% | 1,517,888 | -89.4% | 0.00% | -88.2% |
| Q4 2015 | $14,270,000 | -48.3% | 14,269,775 | +55.2% | 0.02% | -48.5% |
| Q3 2015 | $27,582,000 | +82.5% | 9,193,989 | +204.2% | 0.03% | +94.1% |
| Q2 2015 | $15,111,000 | +57.9% | 3,022,213 | +57.9% | 0.02% | +54.5% |
| Q1 2015 | $9,573,000 | -49.6% | 1,914,341 | -49.6% | 0.01% | -38.9% |
| Q4 2014 | $18,985,000 | -48.6% | 3,796,453 | -48.6% | 0.02% | -50.0% |
| Q3 2014 | $36,966,000 | -58.1% | 7,393,002 | -16.3% | 0.04% | -61.3% |
| Q2 2014 | $88,278,000 | +175.3% | 8,827,737 | +10.1% | 0.09% | +158.3% |
| Q1 2014 | $32,068,000 | +42.8% | 8,016,952 | +78.5% | 0.04% | +50.0% |
| Q4 2013 | $22,459,000 | -27.0% | 4,491,044 | -27.0% | 0.02% | -35.1% |
| Q3 2013 | $30,771,000 | +18.4% | 6,154,022 | +54.1% | 0.04% | +15.6% |
| Q2 2013 | $25,986,000 | – | 3,994,721 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greywolf Capital Management LP | 7,206,570 | $37,582,000 | 6.66% |
| AYM CAPITAL, LLC | 1,417,300 | $7,392,000 | 5.50% |
| AYM CAPITAL, LLC | 655,000 | $3,416,000 | 2.54% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,810,250 | $9,440,000 | 2.51% |
| Beach Point Capital Management LP | 1,902,100 | $9,919,000 | 2.37% |
| Cohen Capital Management, Inc. | 503,000 | $2,623,000 | 0.68% |
| Tourbillon Capital Partners, L.P. | 3,300,000 | $17,210,000 | 0.46% |
| EQUITEC SPECIALISTS, LLC | 288,700 | $1,504,000 | 0.39% |
| Old West Investment Management, LLC | 116,676 | $608,000 | 0.38% |
| Adamant Biomedical Investments AG | 300,000 | $1,564,000 | 0.37% |